Cargando…
Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancer
Biomarkers are needed in muscle-invasive bladder cancer (MIBC). We previously reported that high tumor aurora kinase (AURK) A expression identifies patients with MIBC with poor prognosis. Aberrant p53 expression has also been associated with poor outcomes in MIBC, though to the best of our knowledge...
Autores principales: | Burgess, Earle F., Livasy, Chad, Trufan, Sally, Zhu, Jason, O'Connor, Hazel F., Hartman, Aaron, Clark, Peter E., Grigg, Claud, Raghavan, Derek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022081/ https://www.ncbi.nlm.nih.gov/pubmed/35463214 http://dx.doi.org/10.3892/mco.2022.2535 |
Ejemplares similares
-
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer
por: Zhu, Jason, et al.
Publicado: (2023) -
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients
por: Sanders, J. Alexa, et al.
Publicado: (2021) -
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients
por: Shahid, Zainab, et al.
Publicado: (2023) -
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
por: Grigg, Claud, et al.
Publicado: (2016) -
Aurora 7: the Mercury space flight of M. Scott Carpenter
por: Burgess, Colin
Publicado: (2016)